Accelerating the discovery of new, more effective therapies to treat cancer > More


An ultra-modern training centre for the next generation of scientists at the heart of Université de Montréal > More

Support IRIC

Multiple opportunities to participate in our discoveries > More


  • June 2, 2016The Cell Cycle: from Mechanisms to Therapy - IRIC 10th International Symposium
AEC v1.0.4

Recent Publications

Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells.Rentas S et al.Nature 2016. > More

Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines that Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase.Fraser C et al.J. Med. Chem. 2016. > More

Importin 8 mediates m7G cap-sensitive nuclear import of the eukaryotic translation initiation factor eIF4E.Volpon L et al.Proc. Natl. Acad. Sci. U.S.A. 2016. > More

GPR56 identifies primary human acute myeloid leukemia cells with high repopulating potential in vivo.Pabst C et al.Blood 2016. > More

Mapping physiological G protein-coupled receptor signaling pathways reveals a role for receptor phosphorylation in airway contraction.Bradley SJ et al.Proc. Natl. Acad. Sci. U.S.A. 2016. > More

ERK1/2-induced phosphorylation of R-Ras GTPases stimulates their oncogenic potential.Frémin C et al.Oncogene 2016. > More

Chromosome-wide histone deacetylation by sirtuins prevents hyperactivation of DNA damage-induced signaling upon replicative stress.Simoneau A et al.Nucleic Acids Research 2016. > More

Econazole Imprinted Textiles with Antifungal ActivityHossain MA et al.Eur. J. Pharmacol. 2016. > More

Cellular localisation of the kinin B1R in the pancreas of streptozotocin-treated rat and the anti-diabetic effect of the antagonist SSR240612.Tidjane N et al.Biol. Chem. 2016. > More

Favorable long-term outcome of patients with multiple myeloma using a frontline tandem approach with autologous and non-myeloablative allogeneic transplantation.Ahmad I et al.Bone Marrow Transplant. 2016. > More

Chemo-genomic interrogation of CEBPA mutated AML reveals recurrent CSF3R mutations and subgroup sensitivity to JAK inhibitors.Lavallée VP et al.Blood 2016. > More